Bridgebio Pharma Inc (BBIO)

Stock-Based Compensation

$111.95M

TTM · Period ending: · USD

BBIO logo

BBIO Stock-Based Compensation

Latest reported$111.95M
BBIO TTM Stock-Based Comp ($6.07M → $111.95M)
High-resolution chart · PNG

BBIO stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bridgebio Pharma Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
111,953,000
105,122,000
97,762,000
93,250,000
120,412,000
104,625,000
95,800,000
102,698,000
98,136,000
103,860,000
108,710,000
93,474,000
88,235,000
89,344,000
91,559,000
89,544,000
88,225,000
59,938,000
69,393,000
61,765,000
63,422,000
63,422,000
40,067,000
27,921,000
16,068,000
19,357,000
11,367,000
14,480,000
9,820,000
7,548,000
6,067,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.